ArticleScientific reports2022

Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation.

Laura Acquasaliente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.